4.7 Article

Fluidic system with movable layers for all-in-one assay of cell-free DNA in blood

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 362, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2022.131793

关键词

Circulating cell-free DNA; Sedimentation; Dextran; Microfluidics; Plasma; Filtration

资金

  1. National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2016R1A5A1010148, NRF-2020R1A2B5B01002241]
  2. Korea Institute of Energy Technology Evaluation and Planning (KETEP)
  3. Ministry of Trade, Industry and Energy (MOTIE) [20174010201490]

向作者/读者索取更多资源

This study presents a fully automated and effective fluidic system for the isolation and detection of cfDNA from whole blood. The system utilizes disposable chambers and key components such as the sedimentation chamber and plunger chamber to achieve plasma separation and cfDNA capture, followed by detection using real-time PCR on a chip.
Detection of circulating cell-free DNA (cfDNA) requires multiple processes, including plasma separation, cfDNA isolation, and high-sensitivity detection. However, implementing such processes in a single system in a simple and effective manner is nontrivial. Here, we present a fluidic system for the isolation and detection of cfDNA from whole blood performed in a fully automated and effective manner. The system utilizes vertically mobile top and rotational bottom parts with multiple disposable chambers for sequential processes. The key components for plasma filtration are a sedimentation chamber that enables the dextran-enhanced sedimentation of red blood cells and a plunger chamber with a porous filter and a check valve. cfDNA in the plasma is captured by silica coated magnetic beads in the plunger chamber, washed via the motion of the top and bottom parts, and then detected by real-time on-chip polymerase chain reaction. We vary several parameters, including the plunger speed, dextran concentration, and hematocrit concentration, to optimize the time and efficiency of the assay. The total assay time is 1.5 h with a detection limit of 42 ag/mL for a sample volume of 1.5 mL. Plasma and cfDNA recoveries are 53% and 28%, respectively. Our system is a useful tool for all-in-one assays in liquid biopsies of cancers and other diseases detectable by cfDNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据